Gemcitabine pharmacogenomics: deoxycytidine kinase and cytidylate kinase gene resequencing and functional genomics. - Wikidata - wikimedia - TriplyDB

Gemcitabine pharmacogenomics: deoxycytidine kinase and cytidylate kinase gene resequencing and functional genomics.

Gemcitabine pharmacogenomics: deoxycytidine kinase and cytidylate kinase gene resequencing and functional genomics.

http://www.wikidata.org/entity/Q38500539

about

Immunohistochemical hENT1 expression as a prognostic biomarker in patients with resected pancreatic ductal adenocarcinoma undergoing adjuvant gemcitabine-based chemotherapy.Using RNA-seq and targeted nucleases to identify mechanisms of drug resistance in acute myeloid leukemia.Clinical pharmacology and pharmacogenetics of gemcitabine.Gemcitabine Cytotoxicity: Interaction of Efflux and Deamination.Role of Genetic Polymorphisms of Deoxycytidine Kinase and Cytidine Deaminase to Predict Risk of Death in Children with Acute Myeloid Leukemia.Gemcitabine metabolic pathway genetic polymorphisms and response in patients with non-small cell lung cancer.Genetic variations associated with gemcitabine treatment outcome in pancreatic cancer.Genetic factors influencing cytarabine therapy.New insights into the synergism of nucleoside analogs with radiotherapy Nucleoside analogs: ready to enter the era of precision medicine?Severe acute toxicity following gemcitabine administration: A report of four cases with cytidine deaminase polymorphisms evaluation.Effect of genetic polymorphisms on therapeutic response and clinical outcomes in pancreatic cancer patients treated with gemcitabine.

P2860

Q30238470-08F6C2EF-54EF-44B1-86F9-C56A893A4033 Q34038636-27A446B6-14E2-4303-AC7E-A50B8CC95967 Q34985979-114B8FF5-018A-4AAC-82F1-1653F6315F48 Q35130652-9252DF06-9D05-494C-828E-F38584CF6A3A Q35668858-543038C7-6CB5-4821-912B-E77EEAD8A14D Q35675274-1647A8DB-CDDF-4C55-BA55-B421A6F33D2F Q37372466-8D3AD680-77AC-4C26-93FE-ECF2C8B6E587 Q37618228-8E4E7003-5EAF-470E-BE6B-9C1E034ACE3F Q38143241-1A7A7675-D62E-42F5-BF66-413ED1493A73 Q38842938-5C9CBFC3-99DD-42D7-84F6-330A3FC8E70E Q50053693-50BE14D8-3EB1-418B-B59F-50CDDB37DA5A Q54494355-07F533A5-5F9D-46C6-B61B-D86D1CD03530

P2860

Gemcitabine pharmacogenomics: deoxycytidine kinase and cytidylate kinase gene resequencing and functional genomics.

http://www.wikidata.org/entity/Q38500539

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Gemcitabine pharmacogenomics: ...... ncing and functional genomics.

@en

type

label

Gemcitabine pharmacogenomics: ...... ncing and functional genomics.

@en

prefLabel

Gemcitabine pharmacogenomics: ...... ncing and functional genomics.

@en

P1433

Q38500539-24D05342-1DE1-4C5C-B8B8-C0F837705319

P1476

Q38500539-6F2410A7-E19C-4A36-81A1-85C9A30561AB

P2093

Q38500539-34E941CD-5B31-4593-87EB-3AAD12789831

Q38500539-407B758A-C84F-440B-978B-9B5AD2C6EC67

Q38500539-4C863159-BC85-4B63-B37F-2851218295E6

Q38500539-8E885585-7792-41F5-B4DB-A7413E7141F4

Q38500539-92BFFBCE-1041-45C9-B5DD-C082AD8EDA46

Q38500539-ABD46413-75DE-4C5D-A2E4-C3231C569E89

Q38500539-B05BD7D0-DBA8-4961-B9DD-86D66F45499C

Q38500539-C0EE56BE-B0CD-40D5-A59B-2C30B9C8F6FE

Q38500539-CD0FC059-459F-44BE-8271-F4878C408CE8

Q38500539-D7A98B5F-2CEA-4A6F-837F-770AD23D6A8E

P2860

Q38500539-0070B18F-BBF7-4F52-A25D-683707A44EED

Q38500539-01798698-E1AC-4427-8AFA-4FD94FC66D3F

Q38500539-04C0A8CF-9B45-477B-8399-526577C6CB9A

Q38500539-126810B5-84D2-4767-80A1-EE5096A30654

Q38500539-16F43A76-041D-42CB-9BF8-7C2439C96F10

Q38500539-19494FC4-D22E-46D3-92BF-B833B65E6132

Q38500539-24B256D9-C21A-4A64-80F4-76BE9C008DB2

Q38500539-2B46A02C-0E74-4B6E-B5F3-A6FCA6844017

Q38500539-3D116DD7-A46A-4C2A-81D4-A46F9C12F2FF

Q38500539-3F93A46B-8AE7-4E35-A2FF-47B536234904

P304

Q38500539-CE88CA57-ED36-4306-8BA7-BCD832C57280

P31

Q38500539-32E4D711-48EA-4E36-8988-B01EF4C8CAA6

P356

Q38500539-77EECB89-4843-4E21-89DB-B57C15A5C211

P433

Q38500539-2B908E84-CEDF-4FD5-BCFC-C764445AB326

P478

Q38500539-37FDA5C0-534A-44F6-BB80-D432CD3C46B6

P50

Q38500539-3B526137-CE18-4836-B52B-EDD45096BA88

Q38500539-DAC77555-7CE2-4562-8B5D-3B6CCDC22366

P577

Q38500539-422D5A65-0488-4626-B870-F68114CB2CF5

P5875

Q38500539-2D72A72F-A9CE-4BF8-85DD-B030644A93DF

P698

Q38500539-BC980709-A16F-47EA-9E91-3761D91D0E0C

P921

Q38500539-F76E35E8-6CC7-47DD-9C05-AAD6E86ECEBB

P932

Q38500539-F6FC07D4-5268-4CA7-ACB6-42F610322D64

P356

P1433

Drug Metabolism and Disposition

P1476

Gemcitabine pharmacogenomics: ...... ncing and functional genomics.

@en

P2093

Bruce W Eckloff

http://www.w3.org/2001/XMLSchema#string

Eric D Wieben

http://www.w3.org/2001/XMLSchema#string

Jeong-Seon Ryu

http://www.w3.org/2001/XMLSchema#string

Judith A Gilbert

http://www.w3.org/2001/XMLSchema#string

Linda L Pelleymounter

http://www.w3.org/2001/XMLSchema#string

Matthew M Ames

http://www.w3.org/2001/XMLSchema#string

Neslihan Aygun Kocabas

http://www.w3.org/2001/XMLSchema#string

Oreste Ezequel Salavaggione

http://www.w3.org/2001/XMLSchema#string

Pinar Aksoy

http://www.w3.org/2001/XMLSchema#string

Vivien Yee

http://www.w3.org/2001/XMLSchema#string

P2860

Phosphorylation of deoxycytidine analog monophosphates by UMP-CMP kinase: molecular characterization of the human enzyme

Structure of human dCK suggests strategies to improve anticancer and antiviral therapy

Statistical method for testing the neutral mutation hypothesis by DNA polymorphism

Resistance to gemcitabine in a human follicular lymphoma cell line is due to partial deletion of the deoxycytidine kinase gene

Improved methods for building protein models in electron density maps and the location of errors in these models

Raster3D: photorealistic molecular graphics

Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes

Characterization of human UMP/CMP kinase and its phosphorylation of D- and L-form deoxycytidine analogue monophosphates

Identification of residues involved in the substrate specificity of human and murine dCK

Score tests for association between traits and haplotypes when linkage phase is ambiguous

P304

1951-1959

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1124/DMD.108.020925

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P50

Richard Weinshilboum

P577

2008-06-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5299181

http://www.w3.org/2001/XMLSchema#string

P698

18556440

http://www.w3.org/2001/XMLSchema#string

P921

pharmacogenomics

P932

3066084

http://www.w3.org/2001/XMLSchema#string